Interpace Biosciences (IDXG) EBIT Margin (2009 - 2026)
Interpace Biosciences (IDXG) reported EBIT Margin of 3.52% for Q2 2026, up 8.58 percentage points from -5.07% a year earlier but down 8.92 percentage points from the prior quarter.
Interpace Biosciences (IDXG) EBIT Margin (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Interpace Biosciences' EBIT Margin came in at 11.53%, down 1.06 percentage points year-over-year; for FY2025, it was 10.55%, down 6.73 percentage points from FY2024.
- EBIT Margin has a five-year change of +91.00 percentage points (FY2020 to FY2025).
- By year, EBIT Margin came in at 17.28% in FY2024 (+7.40 pp), 9.88% in FY2023 (+21.24 pp), -11.36% in FY2022 (+7.77 pp) and -19.13% in FY2021 (+61.32 pp).
- Five-year quarterly EBIT Margin spans a low of -25.88% in Q2 2022 and a high of 21.86% in Q2 2024.
- Year over year, EBIT Margin gained in five of the last eight quarters, with an average year-over-year change of -0.73 percentage points.
- The high point for year-over-year EBIT Margin in five years was Q4 2021 (a gain of 67.43 percentage points); the low point was Q2 2025 (a drop of 26.93 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 12.43% (Q1 2026), 17.10% (Q4 2025) and 13.08% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 105.29 Bn | 103.13 Bn | 17.03 Bn | 15.00% |
| 2 | Natera | 46.06 Bn | 41.68 Bn | 513.47 Mn | -8.60% |
| 3 | Labcorp Holdings | 30.09 Bn | 28.19 Bn | 1.11 Bn | 10.55% |
| 4 | Quest Diagnostics | 28.58 Bn | 26.66 Bn | 1.04 Bn | 15.47% |
| 5 | Guardant Health | 20.44 Bn | 16.05 Bn | 236.15 Mn | -36.78% |
| 6 | BrightSpring Health Services | 14.16 Bn | 11.04 Bn | 518.55 Mn | 3.81% |
| 7 | Encompass Health | 13.83 Bn | 14.29 Bn | 1.54 Bn | 13.86% |
| 8 | Tempus AI | 12.69 Bn | 9.84 Bn | 266.70 Mn | -13.82% |
| 9 | Davita | 11.06 Bn | 9.92 Bn | 1.13 Bn | 13.95% |
| 10 | Interpace Biosciences | 167.59 Mn | 158.32 Mn | 5.65 Mn | 3.52% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.52% |
| Mar 31, 2026 | 12.43% |
| Dec 31, 2025 | 17.10% |
| Sep 30, 2025 | 13.08% |
| Jun 30, 2025 | -5.07% |
| Mar 31, 2025 | 15.88% |
| Dec 31, 2024 | 16.61% |
| Sep 30, 2024 | 18.71% |
| Jun 30, 2024 | 21.86% |
| Mar 31, 2024 | 10.95% |
| Dec 31, 2023 | 14.71% |
| Sep 30, 2023 | 4.48% |
| Jun 30, 2023 | 11.01% |
| Mar 31, 2023 | 8.68% |
| Dec 31, 2022 | 0.65% |
| Sep 30, 2022 | -9.52% |
| Jun 30, 2022 | -25.88% |
| Mar 31, 2022 | -12.33% |
| Dec 31, 2021 | -14.84% |
| Sep 30, 2021 | -22.65% |
Interpace Biosciences EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=IDXG&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "IDXG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=IDXG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();